Long-term Reduction in Brain MRI Disease Activity and Atrophy after 5 years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis

D. L. Arnold, L. Kappos, S. L. Hauser, X. Montalban, A. Traboulsee, J. S. Wolinsky, M. Manfrini, V. Levesque, P. Villoslada, S. Belachew, F. Model, S. Hubeaux, A. Bar-Or